- Home
- JBHT vs ICLR Comparison
JBHT vs ICLR Comparison
Compare JBHT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBHT | ICLR |
|---|---|---|
| Founded | 1961 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 14.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | JBHT | ICLR |
|---|---|---|
| Price | $196.81 | $184.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | $172.58 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 01-15-2026 | 10-22-2025 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ 5.00 | N/A |
| EPS | 5.77 | ★ 7.47 |
| Revenue | ★ $12,048,818,000.00 | $8,102,602,000.00 |
| Revenue This Year | $1.31 | N/A |
| Revenue Next Year | $3.88 | $0.76 |
| P/E Ratio | $34.40 | ★ $24.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $122.79 | $125.10 |
| 52 Week High | $204.43 | $228.29 |
Technical Indicators
Market Signals| Indicator | JBHT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 77.10 | 56.92 |
| Support Level | $188.63 | $178.80 |
| Resistance Level | $204.43 | $191.85 |
| Average True Range (ATR) | 4.97 | 7.83 |
| MACD | 1.53 | 0.92 |
| Stochastic Oscillator | 80.59 | 73.09 |
Price Performance
Historical ComparisonAbout JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.